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Abstract
DNA-protein crosslinks (DPCs) are highly cytotoxic lesions that
obstruct essential DNA transactions and whose resolution is criti-
cal for cell and organismal fitness. However, the mechanisms by
which cells respond to and overcome DPCs remain incompletely
understood. Recent studies unveiled a dedicated DPC repair path-
way in higher eukaryotes involving the SprT-type metalloprotease
SPRTN/DVC1, which proteolytically processes DPCs during DNA
replication in a ubiquitin-regulated manner. Here, we show that
chemically induced and defined enzymatic DPCs trigger potent
chromatin SUMOylation responses targeting the crosslinked
proteins and associated factors. Consequently, inhibiting SUMOyla-
tion compromises DPC clearance and cellular fitness. We demon-
strate that ACRC/GCNA family SprT proteases interact with SUMO
and establish important physiological roles of Caenorhabdi-
tis elegans GCNA-1 and SUMOylation in promoting germ cell and
embryonic survival upon DPC formation. Our findings provide first
global insights into signaling responses to DPCs and reveal an
evolutionarily conserved function of SUMOylation in facilitating
responses to these lesions in metazoans that may complement
replication-coupled DPC resolution processes.
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Introduction
The integrity and conservation of DNA are critical for the viability
and fitness of cells and organisms. To mitigate the threat to genome
stability posed by incessant genotoxic insults by endogenous and
exogenous sources, cells launch a global DNA damage response
(DDR), a complex network of processes that cooperatively promote
efficient sensing and repair of different lesions (Jackson & Bartek,
2009; Ciccia & Elledge, 2010). While the repair systems for most
types of DNA damage are now well understood, relatively little is
known about how cells respond to and repair DNA-protein cross-
links (DPCs). DPCs occur frequently and can be classified into two
categories, based on their nature and origin. First, enzymatic DPCs
arise as a consequence of abortive actions of DNA-modifying
enzymes, such as topoisomerases, which form covalent intermedi-
ates with DNA as part of their catalytic mechanism. Second, radia-
tion and reactive chemicals, most prominently aldehydes, generate
non-enzymatic DPCs involving proteins residing in the vicinity of
DNA (Barker et al, 2005; Ide et al, 2011; Stingele et al, 2017). In
fact, formaldehyde, a potent DPC inducer and genotoxin, is gener-
ated in direct proximity to DNA as a byproduct of histone and DNA
demethylation (Walport et al, 2012). Due to their large size, DPCs
can form impassable roadblocks to essential DNA transactions
including DNA replication and transcription and are therefore highly
cytotoxic (Fu et al, 2011; Nakano et al, 2012, 2013).
The toxicity and broad diversity of DPCs that can be formed
likely necessitate a flexible repertoire of cellular mechanisms for
processing these lesions. Until recently, however, the pathways
underlying DPC repair in eukaryotic cells remained largely elusive,
due in part to the heterogeneity of DPCs and a lack of efficient
approaches for the generation of defined DPCs in cells that allow
for unambiguous dissection of the repair mechanisms for these
lesions. Early studies suggested that repair of DPCs involves
nucleotide excision repair (NER) and homologous recombination
(HR), two non-DPC-specific repair pathways, at least in some
contexts (reviewed in Ide et al, 2011). However, more recent find-
ings in yeast, frogs, and mammals revealed the existence of a dedi-
cated, evolutionarily conserved DPC repair mechanism involving a
specialized DNA-activated protease, known as Wss1 in yeast and
SPRTN/DVC1 in higher eukaryotes, which processes DPCs prote-
olytically during DNA replication via an SprT-type metalloprotease
domain (Duxin et al, 2014; Stingele et al, 2014, 2015, 2016; Lopez-
Mosqueda et al, 2016; Vaz et al, 2016). Such SprT protease-
mediated trimming of proteins covalently trapped on DNA may
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facilitate the passage of the replication machinery and enable the
subsequent, full removal of adducted peptide remnants by excision
repair (Duxin et al, 2014). A critical role of SPRTN for genome
stability, longevity, and health in mammals was demonstrated by
recent findings that SPRTN is essential in mice, and that patients
with hypomorphic SPRTN mutations, the underlying genetic
determinant of Ruijs-Aalfs syndrome, manifest with a progeroid
phenotype and early-onset cancer (Lessel et al, 2014; Maskey et al,
2014).
In human cells, the function of SPRTN in processing DPCs is
centrally regulated by ubiquitin, involving a C-terminal ubiquitin-
binding UBZ domain responsible for both its ubiquitin-mediated
recruitment to DNA damage sites and a regulatory switch control-
ling SPRTN proteolytic activity via DPC-sensitive SPRTN monoubiq-
uitylation (Centore et al, 2012; Davis et al, 2012; Mosbech et al,
2012; Lopez-Mosqueda et al, 2016; Stingele et al, 2016; Vaz et al,
2016). By contrast, Wss1 lacks recognizable ubiquitin-binding
domains and instead contains SUMO-interacting motifs (SIMs) that
may facilitate its targeting to and processing of DPCs (Stingele et al,
2014; Balakirev et al, 2015). While no role of SUMO in regulating
SPRTN function has been described, a function of the SUMO E3
ligase ZNF451 (ZATT) in facilitating the resolution of topoisomerase
2 (TOP2) cleavage complexes via tyrosyl-DNA phosphodiesterase 2
(TDP2) that specifically removes TOP2 DNA adducts was recently
reported (Schellenberg et al, 2017). However, whether this mecha-
nism is restricted to this unique type of DNA double-strand break-
associated DPC and precisely how signaling via ubiquitin and SUMO
mechanistically underpins and regulates DPC repair processes
remain unclear.
Here, we uncovered and characterized on a system-wide level a
dynamic SUMO-dependent signaling response to DPCs in human
cells, impacting the trapped proteins and associated chromatin-
bound factors to facilitate DPC clearance and cellular fitness. We
demonstrate that uncharacterized SprT metalloproteases belonging
to the ACRC/GCNA-1 family interact with SUMO and that
Caenorhabditis elegans GCNA-1 promotes organismal survival upon
DPC formation in conjunction with SUMOylation. Collectively, our
findings provide first insights into post-translational modification-
driven signaling responses to DPCs on a global scale and suggest a
central role of SUMOylation in pathways of DPC recognition and
processing that may complement DNA replication-coupled mecha-
nisms for resolving these lesions.
Results
Formaldehyde triggers a dynamic chromatin SUMOylation
response in human cells
To explore the involvement of SUMO in cellular responses to DPCs,
we first analyzed overall SUMOylation profiles of human cells
exposed to the potent DPC inducer formaldehyde (McGhee & von
Hippel, 1977). Strikingly, unlike a range of other genotoxic agents
including ionizing radiation (IR), UV, and hydroxyurea (HU),
formaldehyde elicited a prominent SUMOylation response involving
both SUMO1 and SUMO2/3, which specifically impacted chromatin-
associated but not soluble proteins and correlated with the extent of
DPC formation (Figs 1A–D and EV1A). This effect was apparent at
formaldehyde concentrations that only modestly exceed those of
human blood (100–150 lM; Luo et al, 2001) and was accompanied
by formation of nuclear SUMO2/3 foci colocalizing with PML bodies
in virtually all interphase cells (Figs 1B, and EV1B and C), indicat-
ing that it was not specifically coupled to DNA replication. Indeed,
the DNA polymerase inhibitor aphidicolin had no effect on
formaldehyde-stimulated SUMOylation, which was also unaffected
by inhibition of transcription (Fig EV1D). Like formaldehyde,
treatment of cells with acetaldehyde led to increased chromatin
SUMOylation (Fig EV1E). While aldehydes are potential sources of
DNA interstrand crosslinks (ICLs; Langevin et al, 2011), known ICL-
inducing agents including cisplatin and mitomycin C, which unlike
formaldehyde did not trigger strong DPC formation under our exper-
imental conditions, did not markedly increase chromatin-associated
SUMO2/3 conjugates and nuclear SUMO2/3 foci (Fig 1A–C),
suggesting their formation is not primarily a consequence of ICL
formation. Notably, the formaldehyde-induced increase in chro-
matin SUMOylation was fully reversible, declining sharply to levels
comparable to those of unperturbed cells within hours after
formaldehyde withdrawal (Fig 1D). Consistent with a role of
formaldehyde-induced chromatin-associated SUMO modifications in
the response to DPCs, reducing overall DPC repair capacity through
depletion of the DPC protease SPRTN delayed their reversal
(Fig 1E).
To gain more insight into the dynamic chromatin SUMOylation
response elicited by formaldehyde, we employed an unbiased
proteomic approach to map the cellular proteins modified by
formaldehyde-regulated SUMOylation. To this end, SUMO2 conju-
gates from HeLa cells stably expressing His10-SUMO2 that were
exposed or not to formaldehyde were purified under stringent
conditions (Hendriks & Vertegaal, 2016) and analyzed by mass spec-
trometry (MS) using label-free quantification (Fig 1F; Cox et al,
2014). Pearson correlation showed very high reproducibility
between four individual biological replicates (Fig EV1F–H), and a
total of 1,041 SUMO target proteins were identified (Table EV1).
Among these, 396 proteins consistently showed increased SUMOyla-
tion in response to formaldehyde exposure (FDR < 0.05; Fig 1G;
Table EV1), a large majority (97.3%) of which were annotated as
nuclear proteins (indicated by circles, Fig 1G). Like the overall
SUMO response, the SUMOylation status of most of these factors
returned to baseline levels upon brief recovery from formaldehyde
treatment (indicated by small symbols, Fig 1G). Interestingly,
among the 396 proteins showing formaldehyde-stimulated
SUMOylation, around 46% (182 proteins, names indicated in blue,
Fig 1G) had not previously been identified across a range of similar-
sized SUMO proteomic studies as targets of SUMOylation induced
by cell stresses including heat shock, proteasome inhibition, and
different types of DNA damage, indicating that formaldehyde trig-
gers a cellular stress response that is qualitatively distinct from these
insults. Biochemical analysis of selected factors among this latter
group of proteins confirmed their selective SUMOylation in response
to formaldehyde but not heat shock (Fig 1H). GO term analysis of
proteins displaying formaldehyde-stimulated SUMOylation revealed
selective enrichment of factors involved in DNA-, chromatin-, and
cell cycle-associated processes (Figs 1I and EV1I; Table EV2).
Together, these findings suggest that formaldehyde triggers a highly
dynamic chromatin SUMOylation response with a potential role in
DPC repair processes.
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SUMOylation directly targets defined DNMT1 DPCs
While formaldehyde is a potent inducer of DPCs, it also generates
other forms of macromolecular damage, including protein–protein
crosslinks. To definitively establish whether proteins covalently
trapped on DNA are targeted for SUMOylation, we sought to moni-
tor SUMO signaling in response to more defined DPCs in human
cells. To this aim, we utilized the notion that DNA methyltrans-
ferases, in particular DNMT1 that maintains DNA methylation
patterns in newly replicated DNA, undergo covalent crosslinking to
DNA when acting on the cytosine analog 50-aza-2-deoxycytidine (5-
azadC), which can be efficiently incorporated into chromosomal
DNA during replication (Fig 2A; Du et al, 2015; Maslov et al, 2012).
Strikingly, treatment of cells with 5-azadC triggered a marked DNA
replication-dependent increase in chromatin-associated SUMO
conjugates, accompanied by formation of nuclear SUMO2/3 foci,
that was almost entirely abrogated by knockdown of DNMT1
(Figs 2B and C, and EV2A). By contrast, DNMT1 depletion had no
impact on formaldehyde-induced chromatin SUMOylation, as
expected (Fig EV2A). These findings suggested that the 5-azadC-
induced chromatin SUMOylation response was largely a direct
consequence of DNMT1 DPC formation. Consistently, the cytotoxic-
ity of 5-azadC was alleviated by knockdown of DNMT1 (Fig 2D).
We reasoned that crosslinked DNMT1 molecules might be direct
targets of 5-azadC-induced SUMO modification. Indeed, 5-azadC
treatment led to strongly elevated SUMOylation of wild type DNMT1
but not a catalytically inactive mutant unable to engage in DPC
formation (Fig 2E and F; Schermelleh et al, 2005), suggesting that
SUMOylation might play a role in marking proteins covalently
trapped on DNA for recognition by DPC-processing factors.
To further characterize the 5-azadC-induced SUMOylation
response, we profiled global SUMOylation changes resulting from
exposure to 5-azadC, using a purification and MS scheme similar to
that employed for mapping formaldehyde-regulated SUMOylation
processes (Fig 2G). In agreement with our biochemical observa-
tions, label-free MS-based quantification of four independent biolog-
ical replicates with very high reproducibility revealed that 5-azadC
triggered a massive (~ 94-fold) increase in DNMT1 SUMOylation
levels and that DNMT1 itself was the major cellular substrate of 5-
azadC-stimulated SUMOylation (Figs 2H and EV2B; Table EV3).
Additional proteins were also subject to such modification, although
as compared to the impact of formaldehyde-generated non-specific
DPCs the range of proteins displaying 5-azadC-dependent SUMOyla-
tion was highly restricted (Tables EV1 and EV3). These included the
de novo DNA methyltransferases DNMT3A and DNMT3B, which
like DNMT1 undergo direct 5-azadC-dependent DPC formation but
play back-up roles in replication-coupled DNA methylation (Du
et al, 2015); the DNMT1 partner protein UHRF1, which is essential
for DNMT1-dependent DNA methylation (Du et al, 2015); and
PCNA and the PCNA-interacting protein KIAA0101/PAF15, possibly
reflecting the coupling of DNMT1-mediated DNA methylation to its
association with PCNA at the replication fork. Consistent with our
biochemical observations (Fig 2B), the proteomic analysis further
validated that the majority of 5-azadC-stimulated SUMOylation
events were effectively suppressed by DNMT1 knockdown, imply-
ing their dependency on DNMT1 DPC formation (Fig 2I;
Table EV3). Collectively, these results show that DNMT1 DPC
formation triggers a prominent SUMOylation response that directly
impacts the trapped proteins and associated factors.
SUMOylation is required for resolution of DNMT1-DNA adducts
We next asked whether SUMOylation plays a role in promoting the
resolution of DPCs to protect against their cytotoxicity. To explore
this, we monitored the impact of inhibiting SUMOylation on the
clearance of defined 5-azadC-induced DNMT1 DPCs, using deter-
gent-resistant GFP fluorescence intensity as readout for crosslinked
GFP-DNMT1 molecules in cells stably expressing this transgene
(Schermelleh et al, 2005). Inhibition of 5-azadC-induced chromatin
SUMOylation by knockdown of the SUMO E2 enzyme UBC9 led to a
prominent defect in the removal of trapped GFP-DNMT1 species
following 5-azadC treatment (Figs 3A and B, and EV2C), suggesting
that SUMO-dependent modification facilitates their efficient resolu-
tion. In support of this, UBC9 depletion exacerbated the adverse
effect of 5-azadC on cell proliferation (Fig 3C). Moreover, acute
inhibition of SUMOylation by treatment with ML-792 (SUMO-E1i), a
◀ Figure 1. Formaldehyde triggers a dynamic chromatin SUMOylation response.A Chromatin-enriched fractions of HeLa cells exposed to the indicated genotoxic agents for 1 h were subjected to immunoblot analysis using SUMO2/3 antibody.
B As in (A), except that cells were preextracted in 0.2% Triton X-100, fixed, and immunostained with SUMO2/3 antibody. Representative images are shown. Scale bar,
5 lm.
C Relative DPC levels in cells treated as in (A) were quantified using a KCl/SDS precipitation assay (mean  SD; n = 3 independent experiments).
D HeLa cells were treated with formaldehyde for 1 h, and where indicated, propagated for an additional h in the absence of formaldehyde (recovery). Cells were then
fractionated into soluble and chromatin-enriched fractions and immunoblotted with SUMO2/3 and SUMO1 antibodies.
E As in (D), but using HeLa cells transfected with non-targeting control (CTRL) or SPRTN siRNAs.
F Experimental set-up for global proteomic analysis of formaldehyde-induced SUMOylation changes.
G Mass spectrometry-based analysis of formaldehyde-induced SUMOylation changes. His10-SUMO2 conjugates from HeLa/His10-SUMO2 cells subjected or not to
formaldehyde as shown in (F) were purified on Ni-NTA under stringent conditions and analyzed by mass spectrometry. All proteins displaying significant
upregulation of SUMOylation in response to formaldehyde treatment (Table EV1) were subjected to network analysis using the STRING database, at the default
interaction confidence setting of 0.4. Proteins not connected to the network were omitted.
H SUMO2 conjugates from HeLa/His10-SUMO2 cells subjected or not to formaldehyde or heat stress for 1 h were purified as in (G) and immunoblotted with indicated
antibodies.
I SUMO target proteins displaying at least 2.5-fold upregulation of SUMOylation after formaldehyde treatment were mapped to the human proteome, which was
annotated with Gene Ontology (GO) terms. Enrichment analysis was performed to find terms significantly enriched for formaldehyde-induced SUMOylated proteins,
using Fisher exact testing with multiple-hypothesis correction to achieve a final q-value of < 0.02. A relative score was derived from a combination of the enrichment
ratio and the q-value. A full list of all enriched terms is available (Table EV2). GOBP, GO biological processes; GOCC, GO cellular compartments; GOMF, GO molecular
functions.
Source data are available online for this figure.
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recently described small molecule inhibitor of the SUMO E1 enzyme
SAE (He et al, 2017), abolished 5-azadC-induced chromatin
SUMOylation and strongly impaired the timely clearance of endoge-
nous DNMT1 DPCs (Fig 3D and E). Unlike suppression of SUMOyla-
tion, SPRTN depletion only modestly compromised cell proliferation
and GFP-DNMT1 DPC clearance following 5-azadC treatment while
knockdown of ZNF451, a SUMO E3 ligase recently implicated in
resolving TOP2 DPCs (Schellenberg et al, 2017), had no effect
(Figs 3F, and EV2D and E), suggesting that SUMO-dependent modi-
fication and processing of DNMT1 DPCs can proceed via other enzy-
matic activities. In agreement with the notion that DNMT1
reestablishes DNA methylation patterns following DNA replication,
iPOND analysis (Sirbu et al, 2012) showed that the bulk of DNMT1
species immobilized on 5-azadC-containing DNA as well as accom-
panying SUMO modifications were associated with mature but not
nascent chromatin (Fig 3G). This raises the possibility that the
majority of DNMT1-DNA adducts may be out of reach for
replisome-coupled DPC-processing pathways, consistent with the
modest impact of SPRTN depletion on the clearance of these lesions.
Interestingly, we noted that DNMT1 underwent 5-azadC-induced
ubiquitylation in a SUMO-dependent manner (Fig 3H) and that the
clearance of SUMO-modified DNMT1 molecules trapped on chro-
matin following treatment with 5-azadC was impaired by inhibition
of the proteasome but not DNA replication (Fig 3I and J). These
observations suggest that one route of resolving SUMOylated
DNMT1 DPCs may be via their ensuing ubiquitylation and prote-
olytic processing by the proteasome. We conclude that SUMOylation
plays a critical role in facilitating the resolution of post-replicatively
formed DNMT1-DNA adducts.
The SprT protease ACRC is targeted to DPCs in a SUMO/SIM-
dependent manner
We next asked whether SprT-type proteases, which have recently
been implicated directly in DPC repair (Stingele et al, 2017), are
involved in SUMO-mediated DPC recognition and processing.
◀ Figure 2. DPCs are direct targets of SUMO-dependent modification.A Principle of 5-azadC-induced DNMT1 DPC formation. See main text for details.
B HeLa cells were transfected with non-targeting control (CTRL) or DNMT1 siRNAs, exposed or not to 5-azadC, and collected 2 h later. Chromatin-enriched fractions
were immunoblotted with antibodies to SUMO2/3, DNMT1, and MCM6 (loading control).
C Representative images of HeLa cells that were treated as in (B) and co-immunostained with antibodies to DNMT1, SUMO2/3, and PCNA. Scale bar, 10 lm.
D Proliferative capacity of HeLa/GFP-DNMT1 cells transfected with indicated siRNAs and exposed to the indicated 5-azadC doses for 2 h was assayed by measuring cell
proliferation with the SRB assay (mean  SEM; n = 3 independent experiments; ***P < 0.001, Student’s t-test).
E Extracts of HeLa/GFP-DNMT1 cells treated with 5-azadC for the indicated times were subjected to GFP immunoprecipitation (IP) under denaturing conditions
followed by immunoblotting with SUMO2/3 and GFP antibodies.
F HeLa cells were subjected to consecutive rounds of transfection with DNMT1 siRNA targeting the UTR and expression plasmid encoding WT or catalytically inactive
(CI) GFP-DNMT1. Cells were then left untreated or incubated with 5-azadC for 2 h, and SUMOylation of GFP-DNMT1 was analyzed as in (E). Asterisk denotes
unmodified GFP-DNMT1 recognized by the SUMO2/3 antibody due to weak cross-reactivity.
G Experimental set-up for global proteomic analysis of 5-azadC-induced SUMOylation changes.
H Mass spectrometry analysis of 5-azadC-induced SUMOylation changes. His10-SUMO2 conjugates from HeLa/His10-SUMO2 cells subjected or not to 5-azadC as shown in
(G) were purified on Ni-NTA under stringent conditions and analyzed by mass spectrometry. Proteins displaying significantly altered SUMOylation in response to 5-
azadC treatment relative to the control condition were visualized through two-sample t-testing using permutation-based FDR to achieve q-values of < 0.05 (Table EV3).
I As in (H), except that SUMO target proteins displaying altered SUMOylation upon DNMT1 knockdown are shown. Both control (CTRL) and DNMT1 siRNA-transfected
cells were treated with 5-azadC.
Source data are available online for this figure.
▸Figure 3. SUMOylation promotes resolution of DNMT1-DNA adducts and cell fitness upon 5-azadC treatment.A Chromatin-enriched fractions of HeLa cells transfected with indicated siRNAs and subsequently exposed or not to 5-azadC for 2 h were analyzed by immunoblotting
with SUMO2/3 and actin antibodies.
B HeLa cells stably expressing GFP-DNMT1 and transfected with indicated siRNAs were left untreated or exposed to 5-azadC for 2 h. Cells were then preextracted in
stringent preextraction buffer and fixed at the indicated time points after 5-azadC removal. Mean detergent-resistant GFP signal was determined by quantitative
image analysis (> 6,000 cells analyzed per condition). Data from a representative experiment are shown. Representative images are shown in Fig EV2C.
C Proliferative capacity of HeLa/GFP-DNMT1 cells transfected with control or UBC9 siRNAs and exposed to the indicated 5-azadC doses for 2 h was assayed by
measuring cell proliferation with the SRB assay (mean  SEM; n = 3 independent experiments; ***P < 0.001, Student’s t-test).
D As in (B), except that untransfected HeLa cells were exposed or not to 5-azadC in the presence or absence of a small molecule SUMO E1 enzyme inhibitor (SUMO-E1i).
E HeLa cells treated with 5-azadC for 2 h in the presence or absence of SUMO-E1i were preextracted in stringent preextraction buffer, fixed at the indicated time
points after 5-azadC removal and immunostained with DNMT1 antibody. Mean detergent-resistant DNMT1 signal was determined by quantitative image analysis
(> 6,000 cells analyzed per condition). Data from a representative experiment are shown.
F Proliferative capacity of HeLa cells transfected with SPRTN or ZNF451 siRNAs and exposed to indicated 5-azadC doses for 2 h was assayed as in (C) (mean  SEM;
n = 3 independent experiments; **P < 0.01, n.s. not significant, Student’s t-test).
G iPOND analysis of 5-azadC-induced DNMT1 trapping and SUMOylation. HeLa cells were mock-treated or preincubated with 5-azadC for 5 min before addition of EdU
for 10 min. Cells were then washed and incubated with thymidine for 0 (pulse) or 60 min (chase) before performing iPOND.
H HeLa cells stably expressing GFP-DNMT1 were preincubated or not with SUMO-E1i for 30 min, and where indicated, 5-azadC was added to the medium for an
additional 60 min. Cells were then processed for GFP immunoprecipitation (IP) followed by immunoblotting for the indicated proteins.
I Immunoblot analysis of chromatin-enriched fractions of HeLa cells that were synchronized in early S phase by release from double thymidine block, pulse-labeled
with 5-azadC for 30 min, and grown in the presence or absence of proteasome inhibitor (MG132) for the indicated times.
J As in (I), except that cells were treated or not with aphidicolin following pulse-labeling with 5-azadC.
Source data are available online for this figure.
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Whereas the budding yeast SprT protease Wss1 recognizes SUMO
conjugates via SIMs, SPRTN recruitment to DNA damage sites in
human cells is strongly ubiquitin-dependent and not known to be
regulated by SUMOylation (Centore et al, 2012; Davis et al, 2012;
Mosbech et al, 2012; Stingele et al, 2014; Balakirev et al, 2015).
Consistently, the S phase-specific recruitment of SPRTN to formalde-
hyde-induced nuclear foci was abolished by inhibition of
ubiquitylation but not SUMOylation (Fig 4A–C). Along with SPRTN,
many eukaryotic species encode a second, functionally uncharacter-
ized, SprT domain-containing protease, generally referred to as
GCNA and known in humans as ACRC (Fig 4A); indeed, GCNA
proteases are more closely related to the Wss1 and SPRTN families
than to any other proteases (Carmell et al, 2016). Supporting a
potential involvement of ACRC in cellular responses to DPCs, we
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found that ectopically expressed GFP-tagged ACRC interacted
strongly with polySUMO chains and was recruited to formaldehyde-
induced foci colocalizing with SUMO in virtually all interphase cells,
but did not undergo appreciable accumulation at other types of
DNA damage (Figs 4B and D–F, and EV3A). Likewise, GFP-ACRC
colocalized with DNMT1 following 5-azadC treatment (Fig 4G and
H). Contrary to SPRTN, recruitment of ACRC to formaldehyde- and
5-azadC-induced DPCs was abolished by inhibition of SUMOylation
but not ubiquitylation (Fig 4B, D, G and H). Sequence inspection of
human ACRC revealed the presence of at least four potential SIMs in
its N-terminal portion (Fig 4A), which we surmised might underlie
its SUMO-dependent recruitment to DPCs. Indeed, while mutation
of individual SIMs impaired SUMO binding to different extents,
simultaneous inactivation of all four SIM motifs fully abrogated
ACRC interaction with polySUMO chains and recruitment to
formaldehyde- and 5-azadC-induced nuclear foci (Figs 4F–H and
EV3B–D), suggesting that it recognizes SUMO conjugates at DPC
sites. We conclude from these data that unlike SPRTN, the human
SprT protease ACRC is targeted to DPCs in a SUMO/SIM-dependent
manner.
SUMO and the ACRC ortholog GCNA-1 protect against DPC
toxicity in Caenorhabditis elegans
The findings above suggested that ACRC might have a role in
processing DPCs in a SUMO-driven manner. However, while homo-
logs of ACRC are encoded by many eukaryotic genomes (Carmell
et al, 2016), we found that it was absent or expressed at levels
below the limit of detection in a range of human primary and cancer
cell lines (Bekker-Jensen et al, 2017; our unpublished observations),
in agreement with recent work suggesting that expression of ACRC
orthologs is enhanced in germ and stem cells (Carmell et al, 2016).
Notably, ectopic expression of ACRC in U2OS cells reduced cellular
fitness in a SIM-dependent manner and delayed the clearance of
DNMT1 DPCs (Fig EV3E and F), suggesting that a potential involve-
ment of ACRC in SUMO-mediated responses to DPCs could be
restricted to highly specific cellular settings while enforcing its
expression outside this context may interfere with other DPC-
processing mechanisms. We therefore sought to examine possible
physiological ACRC/GCNA protease functions in DPC responses in a
whole-organism context. To this aim, we utilized the nematode
C. elegans, which contains orthologs of both ACRC and SPRTN
(known as GCNA-1 and DVC-1, respectively; Fig 5A), the latter of
which we and others have previously demonstrated plays an impor-
tant role in promoting survival upon DNA damage, including DPCs,
in this organism (Mosbech et al, 2012; Stingele et al, 2016). Like
human ACRC, we found that GCNA-1 interacted with polySUMO
chains (Fig 5B). We then generated a gcna-1 loss of function (lof)
allele by knocking in a ~ 6.6 kb gfp-containing selection cassette
between the gcna-1 promoter and coding sequence, simultaneously
generating a transcriptional gfp reporter (Figs 5C and EV4A;
Dickinson et al, 2015). Inspection of gcna-1 promoter-driven GFP
expression confirmed that GCNA-1 is mainly expressed in germ cells
and early embryonic, proliferating cells but not in post-mitotic
tissues (Figs 5D and EV4B; Carmell et al, 2016). Interestingly, using
assays probing for survival of germ and early embryonic cells, we
found that gcna-1 loss of function led to elevated formaldehyde
sensitivity (Fig 5E). Likewise, gcna-1 deficiency caused marked
sensitivity to cisplatin but not UV (Figs 5F and EV4C), and GCNA-1
and the core NER factor XPA-1 functioned non-epistatically in
promoting survival upon cisplatin exposure (Fig EV4D). This DNA
damage sensitivity profile showed striking similarities to that
observed for worms lacking DVC-1 (Stingele et al, 2016), which we
independently verified were hypersensitive to formaldehyde and
cisplatin (Fig 5E and F). We observed epistasis between GCNA-1
and DVC-1 in promoting resistance to formaldehyde but not
cisplatin (Fig 5E and F), suggesting that these SprT proteases func-
tion cooperatively in response to formaldehyde-induced DPCs but
have non-redundant roles in pathways responding to the spectrum
of DNA lesions generated by cisplatin. Importantly, like gcna-1 loss-
of-function, an E364Q mutation in GCNA-1 predicted to abolish the
catalytic activity of its SprT protease domain (gcna-1(E364Q)) as well
as an in-frame truncation of this domain gave rise to pronounced
formaldehyde hypersensitivity (Fig 5A, C and G), suggesting that the
putative protease activity of GCNA-1 is essential for its function in
mitigating the toxicity of formaldehyde-induced DPCs.
To probe for a general role of SUMO in promoting survival of
germ and embryonic cells upon exposure to DPC-inducing agents,
▸Figure 4. The SprT protease ACRC but not SPRTN is recruited to DPCs in a SUMO/SIM-dependent manner.A Domain structure of the human SprT proteases SPRTN and ACRC, showing location of SprT protease domains and additional motifs, including a ubiquitin-binding
UBZ domain in SPRTN and an N-terminal cluster of SIMs (sequence highlighted) in ACRC. Alanine substitutions introduced to disrupt the functionality of the ACRC
SIMs (SIM*) are indicated.
B Representative images of U2OS cells stably expressing GFP-SPRTN or GFP-ACRC that were transfected with control (CTRL) or UBC9 siRNAs, exposed to formaldehyde
in the presence or absence of ubiquitin E1 enzyme (UBA1) inhibitor TAK-243 (Ub-E1i) as indicated and fixed one h later. Scale bar, 10 lm.
C Quantification of data in (B), showing proportion of U2OS/GFP-SPRTN cells displaying nuclear GFP-SPRTN foci (mean  SEM; at least 100 cells quantified per
condition per experiment; n = 3 independent experiments).
D As in (C), but showing proportion of U2OS/GFP-ACRC cells displaying nuclear GFP-ACRC foci (mean  SEM; at least 100 cells quantified per condition per experiment;
n = 3 independent experiments).
E U2OS cells expressing GFP-ACRC were exposed to the indicated genotoxic agents (formaldehyde: 600 lM, 1 h; UV: 20 J/m2, 6-h recovery; hydroxyurea (HU): 2 mM,
24 h; mitomycin C (MMC): 40 ng/ml, 24 h), preextracted and fixed, and analyzed by microscopy. Representative images are shown. Scale bar, 10 lm.
F HeLa cells transfected with plasmids encoding GFP alone or indicated GFP-ACRC alleles were subjected to GFP IP under denaturing conditions. Beads were incubated
with recombinant polySUMO22–8 chains, washed extensively, and processed for immunoblotting with SUMO2/3 and GFP antibodies.
G Representative images of U2OS cells expressing indicated GFP-ACRC alleles that were treated with 5-azadC in the presence or absence of SUMO inhibitor (SUMO-E1i),
fixed 2 h later, and immunostained with DNMT1 antibody. Scale bar, 10 lm.
H Quantification of data in (G), showing proportion of cells displaying GFP-ACRC co-localization with DNMT1 foci (mean  SEM; at least 100 cells quantified per
condition per experiment; n = 3 independent experiments).
Source data are available online for this figure.
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we used RNAi to knock down SMO-1, the single SUMO ortholog in
C. elegans (Choudhury & Li, 1997). Depletion of SMO-1 markedly
enhanced formaldehyde sensitivity, an effect recapitulated by
knockdown of the PIAS-type SUMO E3 ligase, GEI-17 (Holway et al,
2006; Figs 5H and I, and EV4E). In line with the possibility that
GCNA-1 promotes resistance to DPC-inducing agents through a
SUMO-dependent pathway, gcna-1 deficiency and SMO-1 knock-
down were epistatic in sensitizing worms to formaldehyde and
cisplatin (Figs 5J and EV4F). Collectively, these data suggest the
existence of a protective SUMO-driven response to DPCs in
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C. elegans germ and embryonic cells, and implicate the GCNA-1
SprT protease as one component involved.
Discussion
Our findings reveal an important role of dynamic SUMO-mediated
protein modifications as a means of promoting cellular responses to
both enzymatic and non-enzymatic DPCs, providing first global
insights into regulatory signaling processes elicited in response to
such insults. Using 5-azadC-induced DNMT1 DPCs as a model
approach for generating defined enzymatic DPCs in human cells, we
show that these lesions trigger a dynamic chromatin SUMOylation
response directly impacting the crosslinked DNMT1 molecules and
known DNMT1-interacting proteins, possibly those residing in close
proximity to the DPCs, in accordance with the SUMO group modifi-
cation principle operating in the context of other types of DNA
damage (Psakhye & Jentsch, 2012). Given that both non-specific
formaldehyde-generated DPCs and defined enzymatic DPCs involv-
ing DNMT proteins stimulate rapid and potent chromatin SUMOyla-
tion targeting diverse and highly defined sets of factors,
respectively, we speculate that SUMO modification of crosslinked
proteins may be a general cellular mechanism to mark covalently
trapped proteins for recognition and processing by SUMO-targeted
components of pathways promoting DPC resolution. The work
described here suggests an involvement of SUMO-binding ACRC/
GCNA family SprT proteases in such processes, and we provide
evidence that in C. elegans germ and early embryonic cells, GCNA-1
has an important role in protecting against the lethality of DPC-indu-
cing agents including formaldehyde in a manner that involves the
integrity of its protease domain and is epistatic with SUMO.
However, it has been shown that GCNA proteases are predomi-
nantly expressed in germ and stem cells (Carmell et al, 2016),
supported by our findings, suggesting that unlike SPRTN, the
involvement of this family of SprT proteases in cellular DPC
responses is, in all likelihood, highly tissue-restricted. While we
have not yet been able to experimentally verify that GCNA-type
proteins are active proteases, this seems warranted by our finding
that point mutation of the highly conserved putative catalytic
glutamic acid residue in the SprT domain of C. elegans GCNA-1
sensitizes worms to formaldehyde to the same extent as gcna-1 loss-
of-function. Establishing the precise role of GCNA-type SprT
proteases in promoting context-specific DPC responses in conjunc-
tion with SUMOylation will be an important task for future investi-
gations.
The importance of SUMOylation in promoting DPC resolution in
human cell lines lacking detectable ACRC expression implies that
other SUMO-targeted DPC-processing factors exist. The SUMO E3
ligase ZNF451/ZATT may be one such protein, as it was recently
implicated in promoting efficient resolution of covalently trapped
TOP2-DNA cleavage complexes, a unique type of enzymatic DPC
involving a phosphotyrosyl linkage in the context of a DNA double-
strand break that is directly reversed in a dedicated process cata-
lyzed by the phosphodiesterase TDP2 (Schellenberg et al, 2017).
However, unlike suppression of SUMOylation, we observed no
adverse impact of ZNF451 depletion on cellular fitness following 5-
azadC-induced DPCs. This suggests that ZNF451 may be primarily
engaged in resolution of TOP2-DNA cleavage complexes but largely
dispensable for the reversal of other types of DPCs that are not
resolved by TDP2, whereas SUMO-dependent signaling could play a
broader role in facilitating the processing of a diverse range of
DPCs. Our studies highlight an interesting division of labor between
ubiquitin- and SUMO-dependent signaling in promoting cellular
responses to these lesions. Available evidence suggests that ubiqui-
tin-regulated SPRTN recruitment to and processing of DPCs is
tightly coupled to DNA replication (Lessel et al, 2014; Lopez-
Mosqueda et al, 2016; Stingele et al, 2016; Vaz et al, 2016). In addi-
tion, recent studies using Xenopus egg extracts revealed a parallel
role of the proteasome and replication fork-associated E3 ubiquitin
ligase activity in DNA replication-coupled DPC repair (Larsen et al,
2018). By contrast, our findings show that chromatin SUMOylation
elicited in response to DPCs does not require ongoing DNA replica-
tion but is operational throughout interphase. Cells may thus
possess complementary ubiquitin- and SUMO-driven pathways for
recognizing and resolving DPCs via mechanisms involving different
protease activities and cell cycle-dependencies. The coordinated
actions of such mechanisms may be important for providing the
flexibility necessary for coping with the diversity of DPC sizes,
▸Figure 5. The ACRC ortholog GCNA-1 and SUMOylation protect against DPC toxicity in Caenorhabditis elegans.A Domain structure of human ACRC and its C. elegans ortholog GCNA-1. The GCNA-1 deletion (del) introduces a frameshift at E364, giving rise to a truncated protein
containing an aberrant 22-residue C-terminal addition.
B HeLa cells transfected with plasmids encoding GFP alone, GFP-ACRC, or GFP-tagged C. elegans GCNA-1 were subjected to GFP IP under denaturing conditions. Beads
were incubated with recombinant polySUMO23–8 chains, washed extensively, and processed for immunoblotting with SUMO2/3 and GFP antibodies.
C Schematic representation of the C. elegans gcna-1 locus, depicting mutants generated. Loss of function gcna-1 allele (emcSi31) was created by knock-in of a gfp
selection cassette (GFP-SEC) in the start codon (see Fig EV4A). gcna-1 deletion (emc52), leading to a frameshift and premature stop codon in the coding sequence,
and E364Q point mutant (emc53) alleles were generated by CRISPR/Cas9 targeting of exon 6.
D GFP expression driven by the gcna-1 promoter was observed in germ cells, proliferating embryos, and young larvae but not in post-mitotic tissues in the head (see
also Fig EV4B). Scale bars, 50 lm.
E Formaldehyde survival of wild type (wt), dvc-1, gcna-1 loss of function (lof), and gcna-1; dvc-1 double mutant C. elegans (mean  SEM; n = 4 independent
experiments).
F Cisplatin survival of wild type, dvc-1, gcna-1, and gcna-1; dvc-1 double mutant C. elegans (mean  SEM; n = 3 independent experiments).
G Formaldehyde survival of gcna-1 deletion (del) and E364Q mutant C. elegans (mean  SEM; n = 2 independent experiments).
H Formaldehyde survival of C. elegans grown on L4440 control (CTRL) or smo-1 RNAi bacteria (mean  SEM; n = 2 independent experiments).
I Formaldehyde survival of C. elegans grown on L4440 control (CTRL) or gei-17 RNAi bacteria (mean  SEM; n = 2 independent experiments).
J Formaldehyde survival of wild type and gcna-1 deletion (del) mutant C. elegans grown on L4440 control (CTRL) or smo-1 RNAi bacteria (mean  SEM; n = 2
independent experiments).
Source data are available online for this figure.
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structures, and modes of DNA attachment that can be encountered.
While the rapid DPC-induced SUMO response can be triggered
throughout interphase, it might be particularly relevant during
conditions where DPC processing by replication-coupled mecha-
nisms is inefficient or even impossible. Indeed, we found that the
majority of 5-azadC-induced DNMT1 DPCs are associated with
mature chromatin but not newly synthesized DNA, raising the
possibility that these lesions are effectively out of reach for the
replication fork-coupled SPRTN and proteasome pathways for DPC
proteolysis. This may account for the strong SUMOylation
response targeting trapped DNMT1 proteins and associated factors,
and could explain the modest impact of depleting SPRTN on
DNMT1 DPC resolution and cellular fitness following 5-azadC
treatment. We therefore suggest that SUMOylation may provide a
means to facilitate the processing of DPCs in duplex DNA that
cannot be efficiently detected and resolved by replication-coupled
DPC repair pathways. Our observations point to a role of DPC
SUMOylation in stimulating subsequent proteolytic processing via
the ubiquitin–proteasome system, but the precise mechanistic
underpinnings remain to be established, and we do not rule out
that additional SUMO-targeted factors may also contribute to the
clearance of SUMO-modified DNMT1 DPCs and other adducted
proteins. Detailed insights into these processes are of considerable
biomedical relevance, given the long-standing use of 5-azadC for
the treatment of myeloid malignancies. Our findings showing that
DNMT1-DNA adduct formation is central to its cytotoxic potential,
which is markedly enhanced by SUMO inhibition, may provide
new opportunities for combination therapies involving 5-azadC
and related drugs.
Collectively, our findings support an important role of SUMO-
dependent signaling in cellular DPC responses that may operate in
parallel with other DPC repair mechanisms to ensure efficient DPC
recognition and resolution in different contexts. Considering the
widespread occurrence of SUMO group modification within the
DNA damage response, whereby multiple factors residing at DNA
damage sites are concurrently targeted by SUMOylation (Psakhye &
Jentsch, 2012), our system-wide analyses of DPC-induced SUMOyla-
tion dynamics may provide a framework for the identification
of additional cellular factors involved in resolution of DPCs to
mitigate the cytotoxicity and disease-promoting potential of these
lesions.
Materials and Methods
Plasmids and siRNAs
Full-length cDNAs encoding human ACRC (Invitrogen UltimateTM
ORF Collection) and C. elegans gcna-1 (synthetic cDNA, codon-opti-
mized for expression in human cells) were cloned into pAcGFP1-C1
vector (Clontech). Plasmid encoding GFP-DNMT1 was a kind gift
from Heinrich Leonhardt, Ludwig Maximilians University, Munich,
Germany. Plasmid encoding GFP-SPRTN was described previously
(Mosbech et al, 2012). ACRC mutants (SIM1*: I22A, L23A, N24A,
V25A; SIM2*: V76A, V77A, V78A, I79A; SIM3*: L97A, L98A, E99A,
I100A; SIM4*: I121A, V122A, I123A, S124A; SIM*: SIM1-4*
combined) and catalytically inactive DNMT1 containing a C1225W
point mutation were generated using the Q5 Site-directed
Mutagenesis Kit (NEB) according to the manufacturer’s protocol.
Plasmid DNA transfections were performed using FuGENE 6 Trans-
fection Reagent (Promega), Novagen GeneJuice Transfection
Reagent (Merck), or Lipofectamine 3000 Reagent (Invitrogen),
according to the manufacturers’ protocols. siRNA transfections were
performed using Lipofectamine RNAiMAX (Invitrogen) according to
the manufacturer’s instructions. All siRNAs were used at a final
concentration of 50 nM unless otherwise indicated. The following
siRNA oligonucleotides were used: non-targeting control (CTRL): 50-
GGGAUACCUAGACGUUCUA-30; UBC9 #1: 50-UAGCUGUCCCAAC
AAAGATT-30; UBC9 #2: 50-GCUCAAGCAGAGGCCUACACGAUUU-30;
SPRTN: 50-UCAAGUACCACCUGUAUUA-30; ZNF451: 50-CAGAAU
UCAGGACACAAAUU-30; DNMT1 #1: 50-CGGUGCUCAUGCUUACAA
C-30; DNMT1 #2 (targeting the 30UTR): 50-CUGUAAUGAGUGGAA
AUUAAGATT-30.
Cell culture
Human U2OS and HeLa cells were obtained from ATCC. All cell
lines used in this study were cultured in DMEM containing 10% FBS
and were regularly tested for mycoplasma infection. The cell lines
were not authenticated. To generate U2OS cell lines constitutively
expressing GFP-ACRC WT, GFP-ACRC SIM* and HeLa cells constitu-
tively expressing GFP-DNMT1, cells were transfected with the
respective expression constructs and positive clones were selected
by incubation in medium containing G418 (InvivoGen) for 14 days.
Stable U2OS cell lines expressing GFP-ACRC alleles in a doxycy-
cline-inducible manner were generated by selection in medium
containing hygromycin B (Thermo Fisher Scientific) and blasticidin
(InvivoGen). Clones were screened for expression of the ectopic
GFP-tagged proteins by microscopy and immunoblotting. U2OS cells
stably expressing GFP-SPRTN and HeLa cells stably expressing
His10-SUMO2 were described previously (Mosbech et al, 2012;
Hendriks & Vertegaal, 2016).
Unless otherwise indicated, the following doses of drugs and
genotoxic agents were used: 5-aza-20-deoxycytidine (5-azadC;
10 lM, Sigma-Aldrich), formaldehyde (600 lM, Merck), acetalde-
hyde (5 mM, Sigma), cisplatin (30 lM, Merck), mitomycin C
(MMC; 15 lM, Merck), hydroxyurea (HU, Sigma-Aldrich; 2 mM),
doxycycline (1 lg/ml, Merck), MLN-7243 (Ub-E1i; 5 lM, Active
Biochem), ultraviolet radiation (UV; 20 J/m2) and ionizing radiation
(IR; 10 Gy), actinomycin D (2 lg/ml, Merck), aphidicolin (APH;
10 lM, Sigma-Aldrich), and ML-792 (SUMO-E1i; 1 lM, synthesized
by MedKoo Biosciences). To induce heat shock, cells were incu-
bated at 43°C for 70 min.
Immunochemical methods, cell fractionation, and antibodies
Immunoblotting was done as previously described (Poulsen et al,
2012). To prepare cell extracts, cells were lysed in EBC buffer
(50 mM Tris, pH 7.5; 150 mM NaCl; 1 mM EDTA; 0.5% NP40;
1 mM DTT) supplemented with protease and phosphatase inhibi-
tors, incubated on ice for 10 min, and cleared by centrifugation. For
immunoprecipitation, cells were lysed in EBC buffer or denaturing
buffer (20 mM Tris, pH 7.5; 50 mM NaCl; 1 mM EDTA; 0.5% NP40;
0.5% SDS, 0.5% sodium deoxycholate; 1 mM DTT) supplemented
with protease and phosphatase inhibitors, and lysates were soni-
cated and cleared by centrifugation. Lysates were incubated with
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GFP-Trap agarose or magnetic beads (Chromotek) for at least 1.5 h.
After extensive washing of the beads, GFP-tagged proteins were
eluted by boiling in 2× Laemmli sample buffer for 5 min and
analyzed by immunoblotting. For chromatin fractionation experi-
ments, cells were lysed in Buffer 1 (10 mM Tris, pH 8.0; 10 mM
KCl; 1.5 mM MgCl2; 0.34 M sucrose; 10% glycerol; 0.1% Triton X-
100) supplemented with protease and phosphatase inhibitors and
incubated on ice for 5 min. After centrifugation at 2,000 g for
5 min, the supernatant contained the soluble proteins. The pellet
was washed in Buffer 1 followed by resuspension in Buffer 2
(50 mM Tris, pH 7.5; 150 mM NaCl; 1% NP40; 0.1% SDS; 1 mM
MgCl2; 125 U/ml benzonase) supplemented with protease and phos-
phatase inhibitors. Lysates were then incubated for 15 min at 37°C
and 1,000 rpm shaking. After centrifugation at 16,000 g for 10 min,
the supernatant contained the chromatin-bound proteins. Isolation
of proteins associated with nascent and mature chromatin by iPOND
was done as previously described (Dungrawala & Cortez, 2015).
Antibodies used in this study included: actin (clone C4,
MAB1501, Merck (1:20,000 dilution), RRID:AB_2223041); DNMT1
(sc-10221 (K-18), Santa Cruz (1:2,000), RRID:AB_2093831); FLAG
(F1804 (M2), Sigma-Aldrich (1:1,000), RRID:AB_262044); GFP (sc-
9996 (Clone B2), Santa Cruz (1:1,000), RRID:AB_627695;
11814460001 (clones 7.1 and 13.1), Roche (1:1,000), RRID:AB_
390913; 902601 (clone B34), BioLegend (1:5,000), RRID:AB_
2565021; sc-8334, Santa Cruz (1:1,000), RRID:AB_641123); MCM6
(C-20, sc-9843, Santa Cruz (1:500), RRID:AB_2142543); PML (sc-
5621 (H-238), Santa Cruz (1:500), RRID:AB_2166848); SAE2 (A302-
580A, Bethyl Laboratories (1:250), RRID:AB_2034860); SPRTN
(kind gift from John Rouse, University of Dundee, UK, (1:1,000));
SUMO1 (4930S, Cell Signaling Technology (1:1,000), RRID:AB_
10698887); SUMO2/3 (ab3742, Abcam (1:1,000), RRID:AB_304041;
ab81371 (8A2), Abcam (1:200), RRID:AB_1658424); TFEB (4240,
Cell Signaling Technology (1:500), RRID:AB_11220225); ubiquitin
(sc-8017 (P4D1), Santa Cruz (1:1,000), RRID:AB_628423); and
ZNF451 (SAB2108741, Sigma-Aldrich (1:500)). Polyclonal sheep
antibody to DNMT1 was raised against full-length recombinant
human DNMT1 purified from bacteria.
KCl/SDS DPC precipitation assay
For isolation of DPCs using the KCl/SDS precipitation assay
(Zhitkovich & Costa, 1992), approximately 1 × 106 cells were lysed
in 1 ml Buffer A (2% SDS; 20 mM Tris, pH 7.5) followed by soni-
cation for 25 s at an amplitude of 25%. Proteins were then precipi-
tated by addition of 1 ml Buffer B (200 mM KCl; 20 mM Tris, pH
7.5) followed by incubation on ice for 5 min. The precipitated
proteins were pelleted by centrifugation at 15,000 g for 5 min
(4°C), and the supernatant was saved for quantification of soluble
DNA. The pellet was washed three times by addition of 750 ll Buf-
fer B followed by incubation at 55°C for 5 min, 30 s on ice, and
centrifugation at 15,000 g at 4°C for 5 min. After washing, each
pellet was resuspended in 500 ll Buffer B containing 0.04 mg/ml
Proteinase K and incubated at 55°C for 3 h. After 30 s on ice and
centrifugation at 15,000 g at 4°C for 5 min, the supernatant
contained the crosslinked DNA. Soluble DNA and crosslinked DNA
were quantified using PicoGreen, and the amount of DPCs was
calculated as the ratio between crosslinked DNA and total DNA
(soluble + crosslinked).
polySUMO-binding assay
HeLa cells expressing GFP-ACRC alleles were lysed in denaturing
buffer supplemented with protease and phosphatase inhibitors, and
lysates were sonicated and cleared by centrifugation. GFP-tagged
ACRC was then purified on GFP-Trap agarose beads (Chromotek)
followed by extensive washing in denaturing buffer. The beads were
equilibrated in EBC buffer and incubated with recombinant
polySUMO22–8 or polySUMO23–8 chains (0.2 lg/sample, Boston
Biochemicals) for 2 h at 4°C with rotation. Bound material was
washed five times in EBC buffer, eluted by boiling in 2× Laemmli
sample buffer for 5 min, and analyzed by immunoblotting.
Immunofluorescence and high-content image analysis
Cells were preextracted in PBS containing 0.2% Triton X-100 for
3 min on ice or in stringent preextraction buffer (10 mM Tris–HCl,
pH 7.4; 2.5 mM MgCl2; 0.5% NP-40; 1 mM PMSF) for 8 min before
fixation with 4% formaldehyde for 10 min. If cells were not preex-
tracted, they were subjected to a permeabilization step with PBS
containing 0.2% Triton X-100 for 5 min after fixation. Coverslips
were incubated with primary antibodies diluted in 1% BSA-PBS for
1 h at room temperature followed by staining with secondary anti-
bodies (Alexa Fluor; Life Technologies) diluted in 1% BSA-PBS for
1 h at room temperature. For manual image acquisition, coverslips
were mounted in Vectashield mounting medium (Vector Laborato-
ries) containing nuclear stain DAPI. For automated image acquisi-
tion, DAPI staining (Thermo Fisher Scientific) was added with
secondary antibodies, and coverslips were mounted in MOWIOL
4-88 (Sigma). For manual image acquisition, we used a Leica
AF6000 wide-field microscope (Leica Microsystems) equipped with
HC Plan-Apochromat 63×/1.4 oil immersion objective, using stan-
dard settings and LAS X software (Leica Microsystems). Raw images
were exported as TIFF files, and if adjustments in image contrast
and brightness were applied, identical settings were used on all
images of a given experiment. For automated image acquisition, an
Olympus IX-81 wide-field microscope equipped with an MT20 Illu-
mination system, Olympus UPLSAPO 20×/0.75 NA objective, and a
digital monochrome Hamamatsu C9100 CCD (charge-coupled
device) camera was used. Automated and unbiased image analysis
was carried out with the ScanR analysis software. Data were
exported and processed using Spotfire (Tibco) software.
Cell proliferation assays
For analysis of cell proliferation, cells were fixed in 10% ice-cold
trichloroacetic acid (TCA) for 30 min. After washing in deionized
water, cells were stained with 0.4% (w/v) sulforhodamine B (SRB)
in 1% acetic acid for 15 min at room temperature. Excess dye was
removed by washing with 1% acetic acid, and plates were dried at
room temperature before the protein-bound fraction was dissolved
in 10 mM Tris, pH 8.0. Fluorescence was measured using microplate
reader FLUOstar Omega using Omega 1.3 software (BMG Labtech).
Enrichment of SUMOylated proteins
Purification of proteins modified by His10-SUMO2 was performed
essentially as described previously (Hendriks & Vertegaal, 2016),
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with the following exceptions: The reduction and alkylation of
peptides during the 100K MWCO filtration step were performed
concomitantly by simultaneous addition of 5 mM chloroacetamide
(CAA) and 5 mM tris(2-carboxyethyl)phosphine (TCEP), as opposed
to sequential incubations with CAA and dithiothreitol (DTT).
Elution of StageTips was performed with 40% acetonitrile (ACN) in
0.1% formic acid, as opposed to 80% ACN in 0.1% formic acid.
Mass spectrometric analysis
Samples were analyzed on 15 cm long analytical columns, with an
internal diameter of 75 lm, and packed in-house using ReproSil-
Pur 120 C18-AQ 1.9 lm beads (Dr. Maisch). Reversed-phase liquid
chromatography was performed using an EASY-nLC 1200 system
(Thermo). The analytical column was heated to 40°C, and elution
of peptides from the column was achieved by application of gradi-
ents with stationary phase Buffer A (0.1% formic acid) and
increasing amounts of mobile phase Buffer B (80% ACN in 0.1%
formic acid). The primary gradient ranged from 5% buffer B to
30% buffer B over 120 min, followed by a tail-end increase to
50% buffer B over 20 min to ensure full peptide elution, followed
by a washing block of 20 min. Electrospray ionization (ESI) was
achieved using a Nanospray Flex Ion Source (Thermo), with the
ions analyzed using either a Q-Exactive HF mass spectrometer
(HF; Thermo) for the formaldehyde experiments or a Q-Exactive
HF-X mass spectrometer (HFX; Thermo) for the 5-azadC experi-
ments. Spray voltage was set to 2 kV, capillary temperature to
275°C, and S-Lens RF level to 50% (HF samples) or funnel RF
level to 40% (HFX samples). Full scans were performed at a reso-
lution of 60,000, with a scan range of 300–1,750 m/z, a maximum
injection time of 60 ms, and an automatic gain control (AGC)
target of 3,000,000 charges. Precursors were isolated with a width
of 1.3 m/z, with an AGC target of 100,000 charges (HF samples)
or 200,000 charges (HFX samples), and precursor fragmentation
was attained using higher-energy collision dissociation (HCD)
using a normalized collision energy of 25. Only precursors with
charge states 2–6 were considered, and selected precursors were
excluded from repeated sequencing by setting a dynamic exclusion
of 60 s. For analysis of the formaldehyde experiments on the HF
instrument, two technical replicates were measured. For the first
replicate, MS/MS settings included a loop count of 12, a maximum
injection time of 50 ms, a resolution of 30,000, and an intensity
threshold of 50,000. For the second replicate, loop count was set
to 7, maximum injection time to 120 ms, resolution to 60,000, and
intensity threshold to 120,000. For analysis of the 5-azadC experi-
ments on the HFX instrument, one technical replicate was
performed, where MS/MS settings included a loop count of 9, a
maximum injection time of 90 ms, a resolution of 45,000, and an
intensity threshold of 120,000.
Raw data analysis
MS proteomics RAW data are available at the ProteomeXchange
Consortium database via the Proteomics Identifications (PRIDE)
partner repository (Vizcaino et al, 2014), under dataset ID
PXD009040. All RAW files were analyzed using MaxQuant software
(version 1.5.3.30; Cox & Mann, 2008; Cox et al, 2011). RAW files
corresponding to the formaldehyde and 5-azadC experiments were
analyzed separately. Default MaxQuant settings were used, with
exceptions outlined below. For generation of the theoretical spectral
library, the HUMAN.FASTA databases were extracted from UniProt
on January 6, 2016 (for formaldehyde experiments) and on Febru-
ary 22, 2017 (for 5-azadC experiments). Protein N-terminal acetyla-
tion and methionine oxidation were included as potential variable
modifications (default), with a maximum allowance of three vari-
able modifications per peptide. Label-free quantification (LFQ) was
enabled. Second peptide search was enabled (default), and match-
ing between runs was enabled with a match time window of 2 min
and an alignment time window of 40 min. Data were filtered by
posterior error probability to achieve a false discovery rate of < 1%
(default), at both the peptide-spectrum match and the protein
assignment levels.
Statistical analysis and data visualization
Processing of the text file output by MaxQuant was entirely
performed using the freely available Perseus software (Tyanova
et al, 2016). Reverse-database hits and potential contaminant
proteins were removed. LFQ intensities were log2-transformed for
further analyses. Proteins not detected in 4 out of 4 biological
replicates in at least one experimental condition were removed.
Scatter plot analysis, principal component analysis, Z-scoring and
subsequent generation of heatmaps, and two-sample testing for
the generation of volcano plots were all carried out in Perseus
using default settings. For determination of whether a protein was
a SUMO target, all His10-SUMO-enriched samples were individu-
ally tested versus the parental control using two-sample testing
and filtered to achieve a permutated-based FDR of < 1% at an s0
setting of 1.5. Potential SUMO targets were moreover filtered to
have at least a ratio of 1.5 over the parental control in at least
one condition, in addition to having set the s0 to 1.5. For assess-
ing differences between the differentially treated SUMO samples,
non-SUMO target proteins were removed, and all remaining
proteins were investigated using two-sample t-testing and filtered
to achieve a permutated-based FDR of < 5% at an s0 setting of
0.5. Interaction network analysis was performed using the
STRING database with default settings (interaction confidence of
0.4; Szklarczyk et al, 2017). Protein interactions were exported,
and visualization was manually performed using Cytoscape (Shan-
non et al, 2003).
Caenorhabditis elegans strains, RNAi and sensitivity assays
All strains were cultured according to standard methods and
outcrossed to N2 wild type (Bristol) at least three times. Alleles used
were dvc-1(ok260) (Mosbech et al, 2012), gei-17(fgp1) and ieIs38
(Pelisch et al, 2017), xpa-1(ok698) and gcna-1(emcSi31, emc52, and
emc53). Loss of function and transcriptional gfp reporter gcna-1
(emcSi31) mutant was generated by knocking in a “GFP-SEC” selec-
tion cassette from plasmid pDD282 (kind gift from Bob Goldstein,
University of North Carolina, Chapel Hill, North Carolina) in the
start codon of gcna-1, according to (Dickinson et al, 2015), by
injecting pDD282 with GFP-SEC flanked by 462 and 618 bp gcna-1
homology arms together with plasmid pJW1219 (Ward, 2015; kind
gift from Jordan Ward, University of California, San Francisco, Cali-
fornia) expressing Cas9 and sgRNA targeting gcna-1 (TGAAG
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ATCTCGAAATGGTGT). gcna-1 deletion (emc52), giving rise to a
truncated protein with a predicted frameshift at E364Q that adds the
22-amino acid sequence AGWSNSFQFLKAISTSSSSYCQ, and E364Q
(emc53) mutants were generated by injection of Cas9 protein
together with tracRNA and crRNA targeting gcna-1 (TTGCTGCATG
ACACAGTTCA; Integrated DNA Technologies), and an ssODN
(GTATGTACAACTGCTGAACGAGTACGAGATACACTGATTCATCA
GCTGTGTCATGCAGCAACATGGGTGGTCGACAGGCTTC) as repair
template to introduce E364Q. Mutant animals were selected by
genotyping PCR. For RNAi experiments, worms were grown on
RNAi bacteria (Source BioScience), for one generation (gei-17) or
7.5 h (smo-1) before treatment. Control RNAi was vector L4440
(kind gift from Andrew Fire, Stanford University, California). To
deplete GFP::degron-tagged GEI-17, animals were grown for 24 h on
plates containing 1 mM auxin (3-indoleacetic acid; Sigma).
Formaldehyde sensitivity was determined by allowing staged young
adults to lay eggs on plates containing formaldehyde (at the indi-
cated dose) for 24 h. Survival was determined by counting dead and
living offspring. Cisplatin sensitivity was determined by allowing
young staged adults, cultured for 24, 48, and 72 h on plates contain-
ing 200 lM cisplatin, to lay eggs for 24 h. Survival was scored by
counting unhatched and hatched eggs. UV survival was determined
as described previously (Lans et al, 2010). Independent survival
assays were performed in quadruplicates or quintuplicates and
replicated at least twice. For microscopy, animals were fixed on
Poly-L-lysine hydrobromide (Sigma) slides with 4% paraformalde-
hyde in PBS, mounted using Vectashield (Vector Laboratories), and
imaged using an LSM700 confocal microscope (Carl Zeiss).
Quantification and statistical analysis
Statistical analysis of data was performed using GraphPad Prism
(version 7). Information about statistical tests is provided in the fig-
ure legends and methods description. No samples were excluded
from the analysis, and no statistical method was used to predeter-
mine sample size. For all experiments, samples were not random-
ized and the investigators were not blinded to the group allocation
during experiments and outcome assessment. Unless otherwise
stated, all experiments were repeated at least three times with simi-
lar outcomes.
Data availability
The mass spectrometry proteomic data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository with
the dataset identifier PXD009040.
Expanded View for this article is available online.
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